deltatrials
Completed PHASE3 NCT00003159

Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer

Randomized Trial of Surgical Resection With or Without Pre-Operative Chemotherapy in Patients With Operable Non-Small Cell Lung Cancer (NSCLC) of Any Stage

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Conditions Lung Cancer
Interventions carboplatin cisplatin conventional surgery docetaxel gemcitabine hydrochloride ifosfamide mitomycin C neoadjuvant therapy paclitaxel vinblastine sulfate vinorelbine tartrate
Updated 5 times since 2017 Last updated: Dec 3, 2013 Started: Aug 31, 1997 Completion: Jun 30, 2007

This PHASE3 trial investigates Lung Cancer and is currently completed. European Organisation for Research and Treatment of Cancer - EORTC leads this study, which shows 5 recorded versions since 1997 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Aug 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • European Organisation for Research and Treatment of Cancer - EORTC
  • Medical Research Council
Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • London, United Kingdom
  • • Sutton, United Kingdom